ArticleBMC pregnancy and childbirth2026
Association between umbilical cord oxidative stress and early neonatal outcomes in gestational diabetes mellitus.
Article in BMC pregnancy and childbirth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGestational diabetes (GDM) is frequently associated with adverse neonatal outcomes, but the underlying mechanisms linking maternal hyperglycemia to fetal harm are not fully understood. Oxidative stress has been suggested as a key pathway; however, studies simultaneously evaluating multiple oxidative and antioxidant biomarkers in umbilical cord blood are limited. This study aimed to investigate the impact of GDM on the fetus by comprehensively evaluating oxidative stress and antioxidant defense mechanisms in umbilical cord blood and to examine their potential associations with neonatal clinical outcomes.
methodsUmbilical cord blood samples were analyzed for malondialdehyde (MDA), membrane attack complex (MAC), total antioxidant status (TAS), total oxidant status (TOS), oxidative stress index (OSI), ischemia-related modified albumin (IMA), 8-hydroxy-2'-deoxyguanosine (8-OHdG), advanced glycation end products (AGEs), reduced glutathione (GSH), and glutathione peroxidase (GPx). Neonatal clinical outcomes were recorded and compared between pregnancies with and without GDM.
resultsAfter correction for multiple biomarker comparisons, MAC, 8-OHdG, and TOS differed significantly between the GDM and non-GDM groups. MAC and 8-OHdG levels were higher in the GDM group, whereas TOS was lower. OSI was higher in the Mann-Whitney analysis but did not remain significant after BH-FDR correction. Exploratory multivariate analyses supported a group-level difference in the combined oxidative-stress biomarker profile, as confirmed by MANOVA and permutation testing. The Spearman heatmap showed that maternal HbA1c was most prominently associated with OSI and also correlated positively with 8-OHdG and GSH. Although neonatal complications were more frequent in the GDM group, oxidative-stress markers were not consistently associated with specific neonatal complications.
conclusionThese findings suggest that GDM is associated with a selective fetal redox-related biomarker pattern rather than a uniform global increase in oxidative stress. The combined biomarker profile and HbA1c-related heatmap correlations indicate that long-term maternal glycemic exposure may influence fetal oxidant-antioxidant balance and oxidative DNA-damage signals, while antioxidant-related responses may remain partially preserved. The comprehensive evaluation of multiple oxidative and antioxidant biomarkers, particularly the inclusion of rarely studied AGEs and IMA, provides a broader perspective on fetal exposure to GDM and its pathophysiological mechanisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.